Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The membrane-type 1 matrix metalloproteinase (MT1-MMP) has been shown to be a key enzyme in tumor angiogenesis and metastasis. MT1-MMP hydrolyzes a variety of extracellular matrix components and is a physiological activator of pro-MMP-2, another MMP involved in malignancy. Pro-MMP-2 activation by MT1-MMP involves the formation of an MT1-MMP.tissue inhibitors of metalloproteinases 2 (TIMP-2). pro-MMP-2 complex on the cell surface that promotes the hydrolysis of pro-MMP-2 by a neighboring TIMP-2-free MT1-MMP. The MT1-MMP. TIMP-2 complex also serves to reduce the intermolecular autocatalytic turnover of MT1-MMP, resulting in accumulation of active MT1-MMP (57 kDa) on the cell surface. Evidence shown here in Timp2-null cells demonstrates that pro-MMP-2 activation by MT1-MMP requires TIMP-2. In contrast, a C-terminally deleted TIMP-2 (Delta-TIMP-2), unable to form ternary complex, had no effect. However, Delta-TIMP-2 and certain synthetic MMP inhibitors, which inhibit MT1-MMP autocatalysis, can act synergistically with TIMP-2 in the promotion of pro-MMP-2 activation by MT1-MMP. In contrast, TIMP-4, an efficient MT1-MMP inhibitor, had no synergistic effect. These studies suggest that under certain conditions the pericellular activity of MT1-MMP in the presence of TIMP-2 can be modulated by synthetic and natural (TIMP-4) MMP inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
Cited by
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
“In addition, by preventing autolytic degradation, MMPIs stabilize cell-surface MT1-MMP, causing a consequent paradoxical increased activation of MMP-2 (Ref”
BackgroundSelf-citationMetalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Control of matrix metalloproteinase catalytic activity
Ra, H.-J., & Parks, W. C. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.07.001 · Cited by 647
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion
Seiki, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00699-7 · Cited by 406
Assessment of Gelatinases (MMP-2 and MMP-9) by Gelatin Zymography
Toth, M., Sohail, A., & Fridman, R. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-854-2_8 · Cited by 395
Self-citationJacobsen, J. A., Major Jourden, J. L., Miller, M. T., & Cohen, S. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 313
Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation
Annabi, B., Lee, Y., Turcotte, S., Naud, E., Desrosiers, R. R., Champagne, M., Eliopoulos, N., Galipeau, J., & Béliveau, R. (2003) · STEM CELLS · doi:10.1634/stemcells.21-3-337 · Cited by 302
Membrane‐type matrix metalloproteinases
SEIKI, M. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01536.x · Cited by 300
Sparano, J. A., Bernardo, P., Stephenson, P., Gradishar, W. J., Ingle, J. N., Zucker, S., & Davidson, N. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.054 · Cited by 269
BERNARDO, M. M., & FRIDMAN, R. (2003) · Biochemical Journal · doi:10.1042/bj20030557 · Cited by 198
Self-citationLiu, J., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.04.003 · Cited by 170
Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., & Noble-Haeusslein, L. J. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0038-0 · Cited by 163
“SB-3CT is selective for MMP-2 and MMP-9, does not inhibit other MMPs, and inhibits MMP-14 (MT1-MMP) as a simple competitive (reversible) inhibitor [68].”
BackgroundComplex Pattern of Membrane Type 1 Matrix Metalloproteinase Shedding
Toth, M., Hernandez-Barrantes, S., Osenkowski, P., Bernardo, M. M., Gervasi, D. C., Shimura, Y., Meroueh, O., Kotra, L. P., Gálvez, B. G., Arroyo, A. G., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200655200 · Cited by 119
Self-citationZhai, Y., Hotary, K. B., Nan, B., Bosch, F. X., Muñoz, N., Weiss, S. J., & Cho, K. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0231 · Cited by 97
Wisniewski, P., Ellert-Miklaszewska, A., Kwiatkowska, A., & Kaminska, B. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.016 · Cited by 46
Metadata
- Authors
- Toth, M., Bernardo, M. M., Gervasi, D. C., Soloway, P. D., Wang, Z., Bigg, H. F., Overall, C. M., DeClerck, Y. A., Tschesche, H., Cher, M. L., Brown, S., Mobashery, S., & Fridman, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 52
- Pages
- 41415-41423
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2088172329
- Cited by
- 134
- References
- 2
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.